drugset / Trial / NCT05520086
Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
Phase 1/2
Unknown
20 enrolled
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Effice Servicios Para la Investigacion S.L. · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
A phase IIa, open label, non controlled clinical trial to assess the feasibility and safety of allogeneic adipose-derived mesenchymal stem cells (ASC) in the treatment of cicatricial conjunctivitis associated with Lyell's syndrome, Stevens-Johnson's syndrome and mucous membrane pemphigoid with ocular involvement
Timeline
- Start
- 2022-11-11
- Primary completion
- 2024-06-11
- Completion
- 2024-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | adipose-derived adult mesenchymal stem cells | Cell therapy | 12.5 cells | Other |